Drug intelligence / Profile preview

Previderm Keratosis

Development stage
Unknown
Lead developer
Ojer Pharma
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Previderm Keratosis is a topical dermatological product developed by Ojer Pharma, a spin-off of the University of Navarra. It is formulated as a transparent bioadhesive lipogel using the company's proprietary Gel Technology Platform (GTP), which allows for the sustained release of active ingredients and forms a protective film on the skin. The product contains a combination of salicylic acid (2%) and urea (2%). Salicylic acid functions as a keratolytic agent to exfoliate and remove thickened skin, while urea acts as a humectant and softening agent to improve skin hydration and repair. It is specifically indicated for the treatment of hyperkeratosis and keratotic skin conditions, such as calluses, hardness, and rough skin caused by friction or dehydration. The product is currently marketed in Spain, Portugal, and Italy.

Brand names
Previderm Keratosis
Other names
salicylic acid + urea

Beyond the preview

Go deeper on Previderm Keratosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Previderm Keratosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call